Transcriptome profiling of genes involved in neural tube closure during human embryonic development using long serial analysis of gene expression (long-SAGE)

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 94, Issue 9, 2012, Pages 683-692

  Krupp, Deidre R ^a   Xu, Pu Ting ^a   Thomas, Sophie ^b   Dellinger, Andrew ^a   Etchevers, Heather C ^b   Vekemans, Michel ^b   Gilbert, John R ^a,c   Speer, Marcy C ^a   Ashley Koch, Allison E ^a   Gregory, Simon G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b INSERM   (France)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Homo sapiens; Long SAGE; Neural tube defects; Neurulation

Indexed keywords

BETA1 INTEGRIN; CD99 ANTIGEN; CYSTATHIONINE BETA SYNTHASE; CYTOCHROME P450 REDUCTASE; GLUCOSE TRANSPORTER 1; MICRORNA; MICRORNA 129; MICRORNA 129 5P; MICRORNA 141; MICRORNA 200A; MICRORNA 23AB; MICRORNA 339 5P; SOMATOMEDIN B; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; CHI SQUARE TEST; COMPUTER MODEL; DEVELOPMENTAL STAGE; EMBRYO; FISHER EXACT TEST; FKBP8 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LIBRARY; GENE MAPPING; GESTATIONAL AGE; GTF2IRD1 GENE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NEURAL TUBE; NEURAL TUBE DEFECT; NEURULATION; PFN1 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; RNA EXTRACTION; SALL1 GENE; SERIAL ANALYSIS OF GENE EXPRESSION; TPT1 GENE; VALIDATION PROCESS;

ABORTION, LEGAL; CHROMOSOME MAPPING; COMPUTER SIMULATION; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMIC LIBRARY; HUMANS; IN SITU HYBRIDIZATION; MICRORNAS; MODELS, GENETIC; NEURAL TUBE; NEURAL TUBE DEFECTS; NEURULATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

HOMO SAPIENS;

EID: 84866033867     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23040     Document Type: Article

References (59)

1. Aitola MH, Pelto-Huikko MT.(2003. Expression of Arnt and Arnt2 mRNA in developing murine tissues. J Histochem Cytochem 51: 41-54.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
3. Cao X, Pfaff SL, Gage FH. 2007. A functional study of miR-124 in the developing neural tube. Genes Dev 21: 531-536.
4. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304.
5. Chang H, Zhang T, Zhang Z, et al. 2011. Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J Nutr Biochem 22: 1172-1177.
6. Chang TI, Horal M, Jain SK, et al. 2003. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46: 538-545.
7. Chen X, Guo J, Lei Y, et al. 2010. Global DNA hypomethylation is associated with NTD-affected pregnancy: a case-control study. Birth Defects Res A Clin Mol Teratol 88: 575-581.
8. Choi PS, Zakhary L, Choi W-Y, et al. 2008. Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron 57: 41-55.
9. Copp AJ, Greene NDE. 2010. Genetics and development of neural tube defects. J Pathol 220: 227-230.
10. Copp AJ, Greene NDE, Murdoch JN. 2003. The genetic basis of mammalian neurulation. Nat Rev Genet 4: 784-793.
11. Crossley M, Whitelaw E, Perkins A, et al. 1996. Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Mol Cell Biol 16: 1695-1705.
12. Detrait ER, George TM, Etchevers HC, et al. 2005. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol 27: 515-524.
13. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. 2003. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 13: 773-780.
14. Etchevers HC, Vincent C, Le Douarin NM, Couly GF. 2001. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 128: 1059-1068.
15. Farh KK-H, Grimson A, Jan C, et al. 2005. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821.
16. Garabedian BH, Fraser FC. 1993. Upper and lower neural tube defects: an alternate hypothesis. J Med Genet 30: 849-851.
17. Greene NDE, Copp AJ. 2009. Development of the vertebrate central nervous system: formation of the neural tube. Prenat Diagn 29: 303-311.
18. Groenen PM, Peer PG, Wevers RA, et al. 2003. Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 189: 1713-1719.
19. Han L, Witmer PD, Casey E, et al. 2007. DNA methylation regulates microRNA expression. Cancer Biol Ther 6: 1284-1288.
20. Harris MJ, Juriloff DM. 2010. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 88: 653-669.
21. Harris MJ, Juriloff DM. 2007. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res A Clin Mol Teratol 79: 187-210.
22. Ichi S, Costa FF, Bischof JM, et al. 2010. Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development. J Biol Chem 285: 36922-36932.
23. Ji X, Takahashi R, Hiura Y, et al. 2009. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55: 1944-1949.
24. Kaczynski J, Cook T, Urrutia R, et al. 2003. Sp1- and Krüppel-like transcription factors. Genome Biol 4: 206.
25. Kanehisa M, Goto S, Sato Y, et al. 2011. KEGG for integration and interpretation of large-scale molecular data sets. Nucl Acids Res 40(Database issue): D109-D114
26. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
27. Kozak KR, Abbott B, Hankinson O. 1997. ARNT-deficient mice and placental differentiation. Dev Biol 191: 297-305.
28. Lagos-Quintana M, Rauhut R, Yalcin A, et al. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739.
29. Lau P, Verrier JD, Nielsen JA, et al. 2008. Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci 28: 11720-11730.
30. Laub F, Aldabe R, Friedrich VJr, et al. 2001a. Developmental expression of mouse Krüppel-like transcription factor KLF7 suggests a potential role in neurogenesis. Dev Biol 233: 305-318.
31. Laub F, Aldabe R, Ramirez F, Friedman S. 2001b. Embryonic expression of Krüppel-like factor 6 in neural and non-neural tissues. Mech Dev 106: 167-170.
32. Liang Y, Ridzon D, Wong L, et al. 2007. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8: 166.
33. Liu Y, Huang T, Zhao X, Cheng L. 2011. MicroRNAs modulate the Wnt signaling pathway through targeting its inhibitors. Biochem Biophys Res Comm 408: 259-264.
34. Lu J, Lal A, Merriman B, et al. 2004. A comparison of gene expression profiles produced by SAGE, long SAGE, and oligonucleotide chips. Genomics 84: 631-636.
35. Mackay DR, Hu M, Li B, Rhéaume C, Dai X. 2006. The mouse Ovol2 gene is required for cranial neural tube development. Dev Biol 291: 38-52.
36. Maere S, Heymans K, Kuiper M. 2005. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21: 3448-3449.
37. Man MZ, Wang X, Wang Y. 2000. POWER_SAGE: comparing statistical tests for SAGE experiments. Bioinformatics 16: 953-959.
38. Mao J, McKean DM, Warrier S, et al. 2010. The iron exporter ferroportin 1 is essential for development of the mouse embryo, forebrain patterning and neural tube closure. Development 137: 3079-3088.
39. Margulies EH, Innis JW. 2000. eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE). Bioinformatics 16: 650-651.
40. McMahon K, Cope H, Heise E, et al. 2011. Descriptive life experiences of adults with myelomeningocele. Presented at the 7th International Conference on Neural Tube Defects; Austin, Texas.
41. Okamoto S, Sherman K, Bai G, Lipton SA. 2002. Effect of the ubiquitous transcription factors, SP1 and MAZ, on NMDA receptor subunit type 1 (NR1) expression during neuronal differentiation. Brain Res Mol Brain Res 107: 89-96.
42. Packer AN, Xing Y, Harper SQ, et al. 2008. The Bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 28: 14341-14346.
43. Petrini J, Damus K, Russell R, et al. 2002. Contribution of birth defects to infant mortality in the United States. Teratology 66: S3-S6.
44. Saha S, Sparks AB, Rago C, et al. 2002. Using the transcriptome to annotate the genome. Nat Biotechnol 20: 508-512.
45. Scott HS, Chrast R. 2002. Global transcript expression profiling by serial analysis of gene expression (SAGE). In: Setlow JK, editor. Genetic engineering: principles and methods. Boston: Kluwer Academic Publishers. pp. 201-219.
46. Shamir R, Maron-Katz A, Tanay A, et al. 2005. EXPANDER - an integrative program suite for microarray data analysis. BMC Bioinformatics 6: 232.
47. Smirnova L, Gräfe A, Seiler A, et al. 2005. Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21: 1469-1477.
48. Song J, Mangold M, Suske G, et al. 2001. Characterization and promoter analysis of the mouse gene for transcription factor Sp4. Gene 264: 19-27.
49. Song J, Murakami H, Tsutsui H, et al. 1999. Structural organization and expression of the mouse gene for Pur-1, a highly conserved homolog of the human MAZ gene. Eur J Biochem 259: 676-683.
50. Ulitsky I, Laurent LC, Shamir R. 2010. Towards computational prediction of microRNA function and activity. Nucl Acids Res 38: e160-e160.
51. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. 1995. Serial analysis of gene expression. Science 270: 484-487.
52. Waghray A, Schober M, Feroze F, et al. 2001. Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res 61: 4283-4286.
53. Wang L-L, Zhang Z, Li Q, et al. 2009. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 24: 562-579.
54. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66: 33-39.
55. Wilting J, Eichmann A, Christ B. 1997. Expression of the avian VEGF receptor homologues Quek1 and Quek2 in blood-vascular and lymphatic endothelial and non-endothelial cells during quail embryonic development. Cell Tissue Res 288: 207-223.
56. Wong C-M, Wong CC-L, Ng Y-L, et al. 2011. Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery. PLoS ONE 6: e16702.
57. Xu P-T, Li Y-J, Qin X-J, et al. 2006. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis 21: 256-275.
58. Zhang Z, Chang H, Li Y, et al. 2010. MicroRNAs: potential regulators involved in human anencephaly. Int J Biochem Cell Biol 42: 367-374.
59. Zhou B, Wang S, Mayr C, et al. 2007. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 104: 7080-7085.